Search

Abbott Laboratories

Закрыт

СекторЗдравоохранение

106.28 1.76

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

104.19

Макс.

106.71

Ключевые показатели

By Trading Economics

Доход

-149M

928M

Продажи

420M

13B

P/E

Средняя по отрасли

38.989

50.373

Прибыль на акцию

1.42

Дивидендная доходность

2.43

Рентабельность продаж

7.369

Сотрудники

122,000

EBITDA

-1.3B

1.5B

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+14.82% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

2.43%

2.12%

Следующий отчет о доходах

21 янв. 2027 г.

Дата следующей выплаты дивидендов

16 нояб. 2026 г.

Следующая эксдивидендная дата

14 янв. 2027 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.4B

181B

Предыдущая цена открытия

104.52

Предыдущая цена закрытия

106.28

Abbott Laboratories График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

30 окт. 2026 г., 23:06 UTC

Abbott Laboratories shares are trading lower in after-market hours, despite a slight recovery, remaining below Friday's close.

29 окт. 2026 г., 23:02 UTC

Abbott Laboratories shares advanced in after-market trading, supported by strength in the Health Care Equipment sub-sector, significantly above its 20-day moving average.

28 окт. 2026 г., 23:02 UTC

Abbott Laboratories is advancing in after-market trading, reflecting notable strength since Wednesday's close, peaking at 1.43% before slightly retracing.

27 окт. 2026 г., 23:01 UTC

Abbott Laboratories shares advanced in after-market trading, reaching their highest level since Tuesday's close amid strong new home sales data.

26 окт. 2026 г., 23:11 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, reflecting a broader market decline that has persisted since Monday's close.

23 окт. 2026 г., 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

22 окт. 2026 г., 23:51 UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

21 окт. 2026 г., 23:06 UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

20 окт. 2026 г., 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

19 окт. 2026 г., 23:41 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

17 окт. 2026 г., 00:01 UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

16 окт. 2026 г., 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

15 окт. 2026 г., 23:06 UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

14 окт. 2026 г., 23:31 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

13 окт. 2026 г., 20:08 UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

12 окт. 2026 г., 23:06 UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

10 окт. 2026 г., 00:01 UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

9 окт. 2026 г., 22:01 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

8 окт. 2026 г., 22:45 UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

7 окт. 2026 г., 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

6 окт. 2026 г., 20:07 UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

5 окт. 2026 г., 23:05 UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2 окт. 2026 г., 20:07 UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

1 окт. 2026 г., 20:07 UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

30 сент. 2026 г., 20:07 UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

29 сент. 2026 г., 23:00 UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

25 сент. 2026 г., 20:07 UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

24 сент. 2026 г., 19:51 UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

23 сент. 2026 г., 20:01 UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

22 сент. 2026 г., 23:41 UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

Сравнение c конкурентами

Изменение цены

Abbott Laboratories Прогноз

Целевая цена

By TipRanks

14.82% рост

Прогноз на 12 месяцев

Средняя 121.938 USD  14.82%

Максимум 135 USD

Минимум 115 USD

Основано на мнении 19 аналитиков Wall Street, спрогнозировавших целевые цены для Abbott Laboratories на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

19 ratings

17

Покупка

2

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat